← Back to Analyst Consensus 
IMUX Buy
IMMUNIC, INC.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Sep 10, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Sep 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 17, 2026 | Wedbush | initiate | — → Outperform | — | 58% |
| May 22, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Apr 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Apr 17, 2026 | Stifel | initiate | — → Buy | — | 53% |
| Apr 15, 2026 | D. Boral Capital | downgrade | Buy → Hold | — | 34% |
| Mar 24, 2026 | Guggenheim | initiate | — → Buy | — | 52% |
| Mar 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 13, 2026 | D. Boral Capital | maintain | Buy → Buy | $4 | 34% |
| Feb 9, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jan 7, 2026 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Nov 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $8 | 44% |
| Nov 13, 2025 | D. Boral Capital | maintain | Buy → Buy | $8 | 34% |
| Sep 29, 2025 | Chardan Capital | initiate | — → Buy | $3 | 47% |
| Sep 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Sep 25, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Aug 8, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Jun 25, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| Jun 5, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| May 29, 2025 | D. Boral Capital | maintain | Buy → Buy | $10 | 34% |
| May 23, 2025 | B. Riley Securities | reiterate | Buy → Buy | $5 | 55% |
| May 1, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 30, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Apr 16, 2025 | B. Riley Securities | reiterate | Buy → Buy | $6 | 55% |
| Apr 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 10, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Apr 1, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Mar 25, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Feb 26, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Feb 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Feb 20, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Jan 7, 2025 | D. Boral Capital | maintain | Buy → Buy | $17 | 34% |
| Nov 25, 2024 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Nov 7, 2024 | EF Hutton | maintain | Buy → Buy | $17 | 30% |
| Oct 22, 2024 | EF Hutton | maintain | Buy → Buy | $17 | 30% |
| Sep 18, 2024 | EF Hutton | maintain | Buy → Buy | $17 | 30% |
| Sep 16, 2024 | EF Hutton | initiate | — → Buy | $17 | 30% |
| Aug 27, 2024 | B. Riley Securities | initiate | — → Buy | $6 | 55% |
| Jul 16, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $28 | 54% |
| Apr 5, 2024 | Brookline Capital | initiate | — → Buy | $10 | 38% |
| Oct 10, 2023 | Wedbush | maintain | Outperform → Outperform | $7 | 58% |
| Jul 27, 2023 | Wedbush | reiterate | Outperform → Outperform | $5 | 58% |
| Oct 21, 2022 | SVB Leerink | downgrade | Outperform → Market Perform | $5 | — |
| Aug 8, 2022 | Aegis Capital | maintain | — → Buy | $35 | — |
| Jun 3, 2022 | SVB Leerink | maintain | — → Outperform | $9 | — |
| May 18, 2022 | Piper Sandler | maintain | — → Overweight | $39 | 54% |
| Sep 7, 2021 | HC Wainwright & Co. | maintain | — → Buy | $25 | 44% |
| Apr 15, 2021 | Aegis Capital | initiate | — → Buy | $55 | — |
Price Target Trend
Apr 26, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days